LesleyNewman
04-22

$Moderna, Inc.(MRNA)$ is way more than just a vaccine company. They’re aiming to bring up to 10 products to market by 2027,that’s an aggressive pipeline. If trials and approvals go smoothly, we could see them break out across multiple fields. The market hasn’t priced in this potential at all, it feels seriously undervalued to me.

Winning Trades
Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment